Subscribe To
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business updates and financial results for the second quarter ended June 30, 2023. “In the second quarter, we completed an equity financing of $20.0 […] The post Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates appeared...
Read More
Posted: Aug 1 2023, 11:30
Author Name: forextv
Views: 102469